跳至主要内容
临床试验/ACTRN12622001076763
ACTRN12622001076763招募中4 期

A multi-centre, cluster, cross-over pilot study comparing efficacy of magnesium administration on the duration of early atrial fibrillation in intensive care patients requiring vasoactive drug support.

Prof Rinaldo Bellomo0 个研究点目标入组 300 人开始时间: 2022年8月4日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients who are invasively mechanically ventilated and receiving vasoactive agents.

排除标准

  • 1. Patients who are allergic to the allocated trial drug.
  • 2. Patients who have undergone cardiac surgery.
  • 3. Pre-eclampsia, eclampsia, or post-partum hypertension.
  • 4. Patients who are known to have atrial fibrillation.
  • 5. Patients with severe Chronic Kidney Disease (eGFR<30ml/min).
  • 6. Patients who Have severe oliguria (<0.5 ml/kg/hr for 12 hours)
  • 7. Patients with serum total Magnesium level of < 0.4mmol/l.

研究者

发起方
Prof Rinaldo Bellomo

相似试验

Assessment of Magnesium administration effect on... | 临床试验